Professor Emery’s department has a specialist dedicated Early Arthritis Centre, and a musculoskeletal imaging group which has state-of-the-art imaging using lunar expert densitometer (for bone mineral density), specialized high-resolution ultrasound (for soft tissue and bone pathology of peripheral joints), and magnetic resonance imaging (for soft tissue and bone pathology of both axial and peripheral joints). There are also specialized clinics for systemic lupus erythermatosus, vasculitis, scleroderma, seronegative spondyloarthropathies, and ultrasound.
There are many clinical studies of inflammatory arthritis being undertaken within Professor Emery’s department, including remission induction and combined monoclonal therapy. Experimental immunotherapy and hemopoietic stem cell replacement are a major interest. The focus of his basic research is the biology of inflammatory cells including lymphocytes, fibroblast and stem cells, both hemopoietic and mesenchymal, and the genetics of persistent inflammation.

1. Outcome in very early inflammatory arthritis
2. Quality of life in patients in remission
3. Quality of life in biologics patients
4. Mesenchymal stem cell biology
5. Biology of FC-gamma receptor polymorphisms
6. Imaging of musculoskeletal conditions
7. Molecular mechanisms of non-response to anti-TNF therapy.

Russell AS, Wallenstein GV, Li T, Martin MC. Maclean R, Blaisdell B, Gajria K, Cole JC, Becker JC, Emery P. Abatacept improves both physical and mental health of rheumatoid arthritis in patients with inadequate response to methotrexate therapy. Ann Rheum Dis. 2007;66:189-194.

Marzo-Ortega H, Green MJ, Keenan AM, Wakefield RJ, Proudman S, Emery P. A randomized Controlled Trial of Early Intervention with Intrarticular Corticosteroids Followed by Sulfasalazine Versus Conservative Treatment in Early Oligoarthritis. Arthritis Rheum. 2007;57:154-160.

Freeston JE, Emery P. The future of imaging in monitoring biologic therapy. Nat Clin Pract Rheumatol. 2007;3:2-3.

Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O’Connor P, Tanner SF, Fraser A, Veale D, Emery P. Efficacy of infliximab on MRI determined Bone oedema in Psoriatic Arthritis. Ann Rheum Dis. 2007;epub 10.1136/ard.2006.063818.

Buch MH, Bingham SJ, Bejarano V, Bryer D, White J, Reece R, Quinn MA, Emery P. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switch to etancercept. Arth Car & Res. 2007;57:448-453.

Haugeberg G, Green MJ, Conaghan PG, Quinn M, Wakefield R, Proudman SM, Stewart S, Hensor E, Emery P. Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis. Ann Rheum Dis. 2007;epub 10.1136/ard.2006.067652.